Differential enhancement of collagen crosslink excretion in cases of osteosarcoma and chondrosarcoma

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 10, 2003, Pages 583-588

  Açil, Yahya ^a   Springer, Ingo ^a,d   Behrens, Peter ^b   Ullrich, Klaus Peter ^c   Hedderich, Juergen ^a   Bruns, Juergen ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d NONE   (Germany)

Author keywords

Chondrosarcoma; Cross links; Osteosarcoma; Pyridinoline

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; PYRIDINOLINE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHONDROSARCOMA; CLINICAL ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CROSS LINKING; PROTEIN URINE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHONDROSARCOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR MARKERS, BIOLOGICAL;

EID: 0242329676     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0470-6     Document Type: Article

References (37)

1. Acil Y, Müller PK (1994) A rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). J Chromatogr A 664:183-188
2. Acil Y, Vetter U, Brenner R, Muller PK, Brinckmann J (1995) Ehlers-Danlos syndrome type VI: cross-link pattern in tissue and urine sample as a diagnostic marker. J Am Acad Dermatol 33:522-524
3. Acil Y, Brinckmann J, Notbohm H, Muller PK, Batge B (1996) Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) Scand J Clin Lab Invest 56:275-283
4. Acil Y, Terheyden H, Dunsche A, Fleiner B, Jepsen S (2000) Three-dimensional cultivation of human osteoblast-like cells on highly porous natural bone mineral. J Biomed Mater Res 51:703-710
5. Acil Y, Springer ING, Prasse JG, Hedderich J, Jepsen S (2002) Concentration of collagen cross-links in human dentin bears no relation to the individual age. Int J Legal Med 116:340-343
6. Akesson K (1995) Biochemical markers of bone turnover. A review. Acta Orthop Scand 66:376-386
7. Body JJ, Delmas PD (1992) Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab 74:471-475
8. Branca F, Robins SP, Ferro-Luzzi A, Golden MH (1992) Bone turnover in malnourished children. Lancet 340:1493-1496
9. Bull H, Murray PG, Thomas D, Fraser AM, Nelson PN (2002) Acid phosphatases. Mol Pathol 55:65-72
10. Chindia ML (2001) Osteosarcoma of the jaw bones. Oral Oncol 37:545-547
11. Coleman RE, Purohit OP, Black C, Vinholes JJ, Schlosser K, Huss H, Quinn KJ, Kanis J (1999) Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease. Ann Oncol 10:311-316
12. Davis GJ, Kapatkin AS, Craig LE, Heins GS, Wortman JA (2002) Comparison of radiography, computed tomography, and magnetic resonance imaging for evaluation of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 220:1171-1176
13. Delmas PD (1992) Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone 13:S17-S21
14. Demers LM, Costa L, Lipton A (2000) Biochemical markers and skeletal metastases. Cancer 88:2919-2926
15. Eyre D (1992) New biomarkers of bone resorption. J Clin Endocrinol Metab 74:470A-470C
16. Fontana A, Delmas PD (2000) Markers of bone turnover in bone metastases. Cancer 88:2952-2960
17. Hoskin PJ, Stratford MR, Folkes LK, Regan J, Yarnold JR (2000) Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Lancet 355:1428-1429
18. Izumi M, Nakanishi Y, Takayama K, Kimotsuki K, Inoue K, Wataya H, Minami T, Hara N (2001) Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma. Cancer 91:1487-1493
19. Liesegang A, Ursprung R, Gasser J, Sassi ML, Risteli J, Riond JL, Wanner M (2002) Influence of dietary phosphorus deficiency with or without addition of fumaric acid to a diet in pigs on bone parameters. J Anim Physiol Anim Nutr (Berl) 86:1-16
20. Liubimova NV, Bronnikov II, Robins SP, Trapeznikova MF, Kushlinskii NE (2000) The biochemical markers of bone remodeling in cancer patients with skeletal involvement. Vopr Onkol 46:290-297
21. Marttunen MB, Hietanen P, Titinen A, Roth HJ, Viinikka L, Ylikorkala O (1999) Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer. Calcif Tissue Int 65:365-368
22. Meyer S, Reinhard H, Graf N, Puschel W, Ziegler K, Schneider G (2002) The importance of conventional radiographs in the diagnosis of osteosarcoma. Klin Padiatr 214:58-61
23. Papatheofanis FJ (1997) Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma. J Nucl Med 38:1175-1179
24. Pecherstorfer M, Zimmer-Roth I, Schilling T, Woitge HW, Schmidt H, Baumgartner G, Thiebaud D, Ludwig H, Seibel MJ (1995) The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab 80:97-103
25. Saifuddin A (2002) The accuracy of imaging in the local staging of appendicular osteosarcoma. Skeletal Radiol 31:191-201
26. Springer ING, Suhr M, Fleiner B (2002) Adaptive adjustment of the adolescent porcine mandibular condyle. Bone 31:1190-1195
27. Springer ING, Terheyden H, Dunsche A, Czech N, Tiemann M, Hedderich J, Açil Y (2003) Collagen crosslink excretion and staging of oral cancer. Br J Cancer 88:1105-1110
28. Stone PJ, Bryan-Rhadfi J, Shaw HA, Franzblau C (1992) Isolation of hydroxylysyl pyridinoline, a mature collagen crosslink from neonatal rat aorta smooth muscle cell cultures. Matrix 12:381-387
29. Takeuchi S, Arai K, Saitoh H, Yoshida K, Miura M (1996) Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer. J Urol 156:1691-1695
30. Tamada T, Sone T, Tomomitsu T, Jo Y, Tanaka H, Fukunaga M (2001) Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy. J Bone Miner Metab 19:45-51
31. Tamura H, Ishii S, Ikeda T, Enomoto K, Kitajima M (1999) The relationship between urinary pyridinoline, deoxypyridinoline and bone metastasis in a rat breast cancer model. Breast Cancer 6:23-28
32. Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE (1996) Metabolic effects of pamidronate in patients with metastatic bone disease. Br J Cancer 73:1089-1095
33. Walls J, Assiri A, Howell A, Rogers E, Ratcliffe WA, Eastell R, Bundred NJ (1999) Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases. Br J Cancer 80:1265-1270
34. Walne AJ, Jenkins PJ, James IT, Plowman PN (1997) Pyridinium crosslinks in the monitoring of patients with bone metastases from carcinoma of the breast. Clin Oncol 9:30-34
35. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, Malawer MM (2002) Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 65:1123-1132
36. Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ (1999) Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res 14:792-801
37. Woitge HW, Pecherstorfer M, Horn E, Keck AV, Diel IJ, Bayer P, Ludwig H, Ziegler R, Seibel MJ (2001) Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Br J Cancer 84:344-351